Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Boya Kangtai Bioengineering Technology is a biotechnology company focused on the field of regenerative medicine and cell therapy. Based in Beijing, the company provides professional services in stem cell and immune cell storage, including umbilical cord, placenta, and adult peripheral blood cell banking. Boya Kangtai also conducts research and development into cell-based treatments for degenerative diseases, immune system modulation, and anti-aging applications. The company operates advanced laboratory facilities that adhere to international standards for cell processing, cryopreservation, and quality assessment. Their business model integrates clinical-grade cell banking with translational research to support the growing demand for personalized medicine in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Boya Kangtai Bioengineering Technology.